Valbiotis SA (FR:ALVAL) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Valbiotis, a French company focused on developing dietary supplements for metabolic disorder prevention and management, reported that its Annual General Meeting took place on June 25, 2024, in La Rochelle, with mixed outcomes for the resolutions presented. While resolutions 1 to 4 and 17 were approved by shareholders, resolutions 5 to 16 were not passed. The company, known for its partnerships and support from the BPI network and the European Union, continues to aim for innovation in health nutrition products.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.